A study published in the Journal of Pediatrics suggests that children born with lower or higher weight than normal may be at increased risk for developing nonalcoholic fatty liver disease (NAFLD). These children also were ...
Apr 19, 2017
0
0
Statin drugs are widely used to manage high cholesterol and reduce the risk of cardiovascular disease. But in a new review of more than 50 studies, researchers cite reductions in liver inflammation and improvements in other ...
Mar 24, 2017
0
0
Among adults in China, those with diabetes diagnosed in middle age lose, on average, nine years of life compared with those without diabetes, according to new research published in the January 17 issue of JAMA.
Jan 17, 2017
0
2
(HealthDay)—For patients with chronic kidney disease (CKD), congestive heart failure (CHF), or chronic liver disease (CLD) with hepatic impairment, metformin use is associated with improvements in clinical outcomes, according ...
Jan 4, 2017
0
3
In a study published in the Journal of Lipid Research, Saint Louis University scientist Angel Baldan, Ph.D., reports that turning off a protein found in liver and adipose tissue significantly improves blood sugar levels, ...
Dec 15, 2016
0
82
According to a new nutritional study conducted by the German Institute of Human Nutrition (DIfE) on individuals with type 2 diabetes, high-protein diets reduced liver fat by up to 48 percent within six weeks. It did not matter ...
Nov 2, 2016
0
0
A new analysis reveals unacceptable mortality rates in young US children with chronic liver disease while they are on transplant waiting lists as well as after transplantation.
Oct 27, 2016
0
0
(HealthDay)—A novel non-elective inpatient hepatology rotation increases knowledge of chronic liver disease (CLD) among internal medicine (IM) residents, according to a study published online Aug. 10 in Hepatology.
Sep 6, 2016
0
0
Up to 70 per cent of Victorians with suspected hepatitis C may not have received follow-up testing, putting them at risk of chronic liver disease and even cancer, University of Melbourne researchers say.
Aug 15, 2016
0
28
A new drug developed by scientists at the National Institutes of Health limits the progression of liver fibrosis in mice, a hopeful advance against a condition for which there is no current treatment and that often leads ...
Jul 28, 2016
0
1
